Viva Vita Diagnostic Systems Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 27-12-2024
- Paid Up Capital ₹ 1.50 Cr
as on 27-12-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 5.88 Cr
as on 27-12-2024
- Satisfied Charges ₹ 3.10 Cr
as on 27-12-2024
- Revenue 30.41%
(FY 2015)
- Profit 105.72%
(FY 2015)
- Ebitda 63.65%
(FY 2015)
- Net Worth 4.15%
(FY 2015)
- Total Assets -17.87%
(FY 2015)
About Viva Vita Diagnostic Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹5.88 Cr. The company has closed loans amounting to ₹3.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajendran Sundaram, Geethanjali Dharmarajan, and Raman Rajeswari serve as directors at the Company.
- CIN/LLPIN
U85110TN2004PTC052749
- Company No.
052749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2004
- Date of AGM
01 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Viva Vita Diagnostic Systems?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendran Sundaram  | Director | 08-Nov-2008 | Current |
| Geethanjali Dharmarajan | Director | 08-Nov-2008 | Current |
| Raman Rajeswari | Additional Director | 18-Mar-2015 | Current |
Financial Performance of Viva Vita Diagnostic Systems.
Viva Vita Diagnostic Systems Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 30.41% increase. The company also saw a substantial improvement in profitability, with a 105.72% increase in profit. The company's net worth moved up by a moderate rise of 4.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Viva Vita Diagnostic Systems?
In 2015, Viva Vita Diagnostic Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 26 Jul 2012 | ₹5.88 Cr | Open |
Tamilnad Mercantile Bank Limited Creation Date: 14 Jul 2011 | ₹0.75 M | Satisfied |
Tamilnad Mercantile Bank Limited Creation Date: 01 Aug 2009 | ₹1.50 M | Satisfied |
How Many Employees Work at Viva Vita Diagnostic Systems?
Unlock and access historical data on people associated with Viva Vita Diagnostic Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Viva Vita Diagnostic Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viva Vita Diagnostic Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
